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Background: Extravascular lung water (EVLW) is a sensitive prognostic indicator of pulmonary edema. Thus, EVLW
may be an advantageous method of fluid management. This study aims to evaluate the outcomes of using EVLW
and pulmonary artery wedge pressure (PAWP) as strategies for fluid management in patients with acute respiratory
distress syndrome (ARDS).
Methods: Twenty-nine patients were randomly divided into the EVLW and PAWP groups. The survival rate, ICU
(Intensive Care Unit) length of stay, duration of mechanical ventilation, acute lung injury scores, and oxygenation
index of the EVLW and PAWP groups were compared.
Results: No significant difference in the survival rates at 28 and 60 days (d) after treatment was found between
the two groups (p = 0.542). The duration of mechanical ventilation and ICU length of stay were significantly lower
(p < 0.05) in the EVLW group than in the PAWP group. The 7 d cumulative fluid balance was −783 ± 391 ml in the
EVLW group and −256 ± 514 ml in the PAWP group (p < 0.05). Compared with the PAWP group, the EVLW group
showed improved oxygenation index (p = 0.006).
Conclusions: EVLW for fluid management improved clinical results in patients with ARDS better than PAWP.
Keywords: Acute respiratory distress syndrome, Extravascular lung water, Fluid management, Pulmonary artery
wedge pressureBackground
Acute respiratory distress syndrome (ARDS) is a life-
threatening form of lung injury that usually occurs with
diseases, such as severe infection, multiple trauma, and
burns. The condition occurs because of the diffuse pul-
monary interstitial and alveolar edemas caused by the
injury of pulmonary capillary and alveolar epithelial cells.
When blood cells are low in oxygen, ARDS becomes a
progressive disease that causes respiratory distress with
extremely high mortality risk. Thus, ARDS is a serious
threat that affects the quality of patients’ lives. Increased
capillary permeability is a pathophysiological hallmark of
ARDS, and the severity of pulmonary edema is positively
associated with the prognosis of ARDS [1]. Therefore,
active fluid management is clinically important to* Correspondence: weihucn@126.com
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stated.ameliorate pulmonary edema. However, fluid manage-
ment in ARDS patients is difficult because a sufficient
volume must be supplied to resuscitate the patient while
avoiding the occurrence or exacerbation of pulmonary
edema [2]. Pulmonary arterial wedge pressure (PAWP)
and central venous pressure (CVP) have long been used
for clinical fluid management in ARDS patients. How-
ever, these methods are not accurate because the rela-
tionship among PAWP, CVP, and cardiac preload may
be affected by several factors [3,4]. The pulse-indicating
continuous heart displacement monitoring technology
(pulse-induced contour cardiac output; PiCCO) was ap-
plied. Extravascular lung water (EVLW) has also been
used as a sensitive prognostic indicator of pulmonary
edema. EVLW has become an important hemodynamic
parameter for bedside monitoring [5-7]. Thus, EVLW
may be a more advantageous method of fluid manage-
ment [7-9]. In this study, we evaluated and comparedThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise













EVLW Group 15 8 7 50 ± 13 22.20 ± 3.14 9.33 ± 2.41 2.78 ± 0.45 127.57 ± 18.59
PAPW Group 14 9 5 49 ± 12 21.93 ± 3.77 9.36 ± 2.34 2.83 ± 0.53 133.73 ± 22.92
Data are shown as mean ± SD.
Table 2 Comparison of duration of mechanical
ventilation, ICU LOS and survivals at 28 days and 60 days












10.13 ± 3.02* 12.53 ± 3.50* 73.33 73.33
PAWP
group
12.64 ± 2.89 15.50 ± 2.50 78.57 78.57
Data are shown as mean ± SD, *p < 0.05 versus PAWP values.
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agement by EVLW and PAWP.
Subjects and methods
Patients
This study was approved by the Ethics Committee. All
29 adult ARDS patients or their guardians signed an in-
formed consent form upon recruitment and enrolment
for this study. All patients were hospitalized at the ICU
(Intensive Care Unit). Patients were diagnosed according
to the American-European Consensus definition of
ARDS provided in 1994: (a) acute onset; (b) bilateral in-
filtrates on chest radiograph consistent with pulmonary
edema; (c) ratio of partial pressure of arterial oxygen
(PaO2) to fraction of inspired oxygen (FiO2) less than
200; and (d) absence of left atrial hypertension. The
study period lasted from January 2009 to November
2011. The study excluded patients with severe pulmon-
ary hypertension, complete left bundle-branch block,
pneumonectomy, interstitial lung disease, and bacterial
endocarditis. Patients discharged against medical advice
were also excluded.
The patients were randomly divided into the EVLW
(n = 15) and PAWP (n = 14) groups. The causes of ARDS
in the EVLW group included severe pneumonia (n = 6),
abdominal infection (n = 3), multiple trauma (n = 2),
H1N1 (n = 2), severe acute pancreatitis (n = 1), and irri-
tant gas inhalation (n = 1). The causes of ARDS in the
PAWP group included severe pneumonia (n = 5), ab-
dominal infection (n = 3), multiple trauma (n = 1), H1N1
(n = 2), severe acute pancreatitis (n = 2), and urinary
tract infection (n = 1). The general characteristics of the
patients from the two groups are listed in Table 1. No
significant differences were observed between the two
groups (p > 0.05).
Methods
All patients admitted to the ICU were treated by mechan-
ical ventilation to manage the primary disease. Mechanical
ventilation was performed according to the protective
ventilation strategy recommended by the ARDS Network.
In general, a pressure control ventilation or biphasic posi-
tive airway pressure mode was adopted, with the con-
trolled peak airway pressure < 35 cm H2O, the plateau
pressure < 30 cm H2O, and the force inspiratory oxygen
and positive pressure respiration set according to titration.The patients were evaluated using Acute Physiology and
Chronic Health Evaluation II and Sequential Organ Fail-
ure Assessment scores. For the EVLW group, a standard
central venous catheter (Arrow Electronics, New York,
USA) was inserted into either the internal jugular or sub-
clavian location, and an arterial catheter (Pulsion Medical
Systems, Munich, Germany) was inserted into the de-
scending aorta via the femoral artery using the Seldinger
technique. During fluid management, EVLW was mea-
sured every 8 h and maintained within 3 ml/kg to 7 ml/kg.
When EVLW reached or exceeded 7 ml/kg, the patient
was treated with diuretics or continuous renal replace-
ment therapy (CRRT). For the PAWP group, a Swan-Ganz
floating catheter (Arrow Electronics, New York, USA) was
inserted into the pulmonary artery using the Seldinger
technique. PAWP was measured every 8 h and maintained
within 8 mm Hg to 12 mm Hg. When PAWP reached or
exceeded 12 mm Hg, treatment with diuretics or CRRT
was performed. All decisions on patient management, in-
cluding fluid and ventilator management, were made by
the primary intensive care physicians caring for the pa-
tient. This study was conducted in accordance with the
declaration of Helsinki. The experiments were approved
by the Ethics Committee of the first People’s Hospital.
Written informed consent was obtained from all
participants.Outcome variables
Vital signs, such as blood pressure, were recorded every
hour. The 24 h intake and discharge fluid volume were
also recorded daily. The acute lung injury score and oxy-
genation index were calculated every 24 h. Survival rates
at 28 and 60 d after treatment were taken as the primary
endpoints. Finally, the ICU length of stay (ICU LOS)
Table 3 Comparison of acute lung injury score in the two groups
Groups Prior treatment The first day post-treatment The third day post-treatment The fifth day post-treatment F p
EVLW group 2.783 ± 0.452 2.667 ± 0.654* 2.311 ± 0.526* 1.867 ± 0.516* 8.678 0.000
PAWP group 2.826 ± 0.526 2.738 ± 0.587* 2.381 ± 0.582* 2.092 ± 0.546* 5.092 0.003
t 0.237 0.307 0.340 1.141 1.302 0.273
p 0.815 0.761 0.736 0.264
Data are shown as mean ± SD, *p < 0.05 versus prior treatment.
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curative effect.
Statistical analysis
Statistical analysis was performed using the software pro-
gram SPSS (version 18.0; Chicago, IL, USA). Enumerated
data were compared using Fisher’s exact test. Continuous
data were presented as mean ± standard deviation and
compared using two-sample t-tests. Variance analysis was
used for the comparisons of data before and after treat-
ment. All statistical tests were two-sided; p < 0.05 was con-
sidered to indicate statistical significance.
Results
Duration of mechanical ventilation, ICU LOS, fluid
balance, and patient survival
The duration of mechanical ventilation and the ICU
LOS of patients were significantly lower in the EVLW
group than in the PAWP group (t = 2.283 and t = 2.612,
respectively; p < 0.05 for both). The 7 d cumulative
fluid balance was −783 ± 391 ml in the EVLW group
and −256 ± 514 ml in the PAWP group (p < 0.05).
Nevertheless, no significant differences were observed
in the number of survivors at 28 and 60 d after treat-
ment between the two groups (p = 0.542 for both;
Table 2).
Acute lung injury scores
After treatment with EVLW or PAWP, the acute lung in-
jury scores of the patients gradually decreased. This re-
sult differed significantly at 1, 3, and 5 d after treatment
(p < 0.05). However, the scores between the two treat-
ment groups were not significantly different (F = 1.302,
p = 0.273; Table 3).Table 4 Comparison of oxygenation index in the two groups




EVLW group 127.568 ± 18.592 147.066 ± 21.339* 173.266 ± 23.25
PAWP group 133.733 ± 22.917 156.000 ± 26.94* 157.857 ± 21.5
t 0.798 0.996 −1.847
p 0.431 0.329 0.076
Data are shown as mean ± SD, *p < 0.05 versus prior treatment. △p < 0.05 versus PAOxygenation index
The oxygenation index dramatically enhanced in the
EVLW and PAWP groups as the treatment was con-
tinued (p < 0.05 for both groups). Significant differ-
ences were observed between the two groups (F = 6.437,
p = 0.006; Table 4).
Discussion
ARDS usually occurs with noncardiogenic diseases, such
as severe infection, shock, trauma, and burns. ARDS is
caused by pulmonary edema in the interstitial and al-
veolar cells, which can be attributed to the damage of
pulmonary capillary and alveolar epithelial cells. Patho-
physiologically, increased capillary permeability impairs
fluid removal from the alveolar space. The accumula-
tion of protein-rich fluids inside the alveoli severely re-
duces lung volume and lung compliance, as well as
disturbs the ventilation-perfusion ratio. ARDS becomes
apparent with progressive hypoxemia, clinical respira-
tory distress, and the heterogeneity of exudative process
in chest radiography [10].
To date, fluid management in patients with ARDS re-
mains an intractable problem. Venous fluid infusion is
important for patients with severely damaged pulmonary
ventilation to maintain a suitable inner capacity and,
consequently, to stabilize blood dynamics and infusion
into major organs. However, excess fluid would worsen
pulmonary edema and thus damage gas exchange. The
strategies used in ICUs for fluid management are classi-
fied into two categories: 1) the opening fluid manage-
ment strategy or wet approach and 2) the restricted or
conserved fluid management strategy or dry approach
[11]. The ARDS network showed that mortality is not
significantly different between the restricted and unre-







1*△ 191.333 ± 21.053*△ 210.066 ± 26.547*△ 33.118 0.000
65* 174.571 ± 16.232* 185.571 ± 17.261* 12.024 0.000
−2.388 −2.922 6.347 0.006
0.024 0.007
WP group.
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uretics and limited fluid infusion) experience a negative
fluid balance on the first week (−136 ± 491 ml vs. 6992 ±
502 ml for unrestricted). Compared with unrestricted
fluid management, restricted fluid management yields
improved oxygenation index, significantly reduced lung
injury score, and significantly shorter ICU LOS [12].
Given the premise of maintaining a stable cycle and
organ perfusion, the use of restricted fluid management
is more favorable for ARDS patients.
The methods for extenuating pulmonary edema may
notably reduce the cardiac output and organ filling de-
fect; however, the incidence of dysfunction in other or-
gans is increased [2,13]. In the present study, the
incidence of shock and hypotension did not increase,
even when restricted fluid management was used in
combination with treatment using diuretics or CRRT.
This result may be attributed to our small sample size.
Further prospective clinical studies should be performed.
EVLW is a unique method for quantitatively monitor-
ing the injury and permeability of pulmonary capillaries.
This parameter is considered an independent risk factor
to predict the severity and prognosis of critically ill pa-
tients [8,9,14-16]. During the progression of ARDS, the
pneumonic oxygenation index and static compliance
sharply decrease as EVLW increases [8,17]. Furthermore,
CVP and PAWP cannot accurately reflect the changes in
pulmonary edema during an illness because the data are
influenced by the altered permeability of the capillaries
and the mechanical ventilation being used [3,4,18,19].
Due to time and objective case constraints, the sample
size in this study is small, and there is no significant dif-
ference at primary endpoint between two groups. Condi-
tions permitting, the sample size should be enlarged for
further investigation.
Conclusions
The prognosis of ARDS can be influenced by several fac-
tors, such as age, primary diseases, and complications
due to multiple organ failure or severe sepsis. These fac-
tors are closely associated with the high fatality rate of
ARDS. Despite the absence of evidence that the negative
fluid balance can be used as an independent prognostic
factor, the results of this study showed that EVLW for
restricted fluid management improves the oxygenation
index better than PAWP. Thus, the duration of mechan-
ical ventilation and ICU LOS can be reduced. Although
no significant differences in the overall mortality were
observed between the two treatments, EVLW has more
clinical value than PAWP in terms of fluid management
in patients with ARDS.
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